Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-8418.0%
operating margin TTM
-18959.73%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -3.21 |
| peg ratio | -0.40 |
| price to book ratio | -0.23 |
| price to sales ratio | 639.68 |
| enterprise value multiple | -4.43 |
| price fair value | -0.23 |
profitability ratios | |
|---|---|
| gross profit margin | -224.41% |
| operating profit margin | -18959.73% |
| pretax profit margin | -17599.33% |
| net profit margin | -8418.0% |
| return on assets | -25.56% |
| return on equity | 7.4% |
| return on capital employed | -63.16% |
liquidity ratios | |
|---|---|
| current ratio | 9.06 |
| quick ratio | 9.06 |
| cash ratio | 3.93 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 423.71 |
| days of payables outstanding | 328.04 |
| cash conversion cycle | 95.67 |
| receivables turnover | 0.86 |
| payables turnover | 1.11 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | -0.00 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | -0.00 |
| interest coverage | -8,871.16 |
| cash flow to debt ratio | -34.95 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.06 |
| cash per share | 1.58 |
| operating cash flow per share | -0.93 |
| free cash flow operating cash flow ratio | 1.13 |
| cash flow coverage ratios | -34.95 |
| short term coverage ratios | -119.32 |
| capital expenditure coverage ratio | -7.41 |
Frequently Asked Questions
When was the last time ProKidney Corp. (NASDAQ:PROK) reported earnings?
ProKidney Corp. (PROK) published its most recent earnings results on 15-05-2026.
What is ProKidney Corp.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. ProKidney Corp. (NASDAQ:PROK)'s trailing twelve months ROE is 7.4%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. ProKidney Corp. (PROK) currently has a ROA of -25.56%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did PROK's net profit margin stand at?
PROK reported a profit margin of -8418.0% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is PROK's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 9.06 in the most recent quarter. The quick ratio stood at 9.06, with a Debt/Eq ratio of -0.00.